Home > Our Indexes > LSCIBP

Download Methodology

LifeSci Biotechnology Products Index

LifeSci Biotechnology Products Index ("LSCIBP") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval. The inception date for LSCIBP was November 3, 2014.

Prior Day Closing Value7449.1
Prior Day Change %-2.02%
Current Day Change %+1.41%

Top 10 Constituents (Dec 15, 2017)

Constituent Ticker Weight
Nektar Therapeutics NKTR 8.02%
Enanta Pharmaceuticals Inc ENTA 4.52%
Neurocrine Biosciences Inc NBIX 4.17%
Sarepta Therapeutics Inc SRPT 4.12%
Halozyme Therapeutics Inc HALO 3.87%
Exelixis Inc EXEL 3.45%
Biogen Inc BIIB 3.36%
Acorda Therapeutics Inc ACOR 3.17%
Retrophin Inc RTRX 3.11%
Gilead Sciences Inc GILD 3.06%
Data Updated Daily
Download All Constituents